Series 5 Labs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 624.14%
- Profit Growth -20.75%
- Ebitda -24.19%
- Net Worth -30.90%
- Total Assets 7.18%
About Series 5 Labs
Series 5 Labs Private Limited (S5LPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 22 December 2016 (Eight years and two months 5 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Karakkad Vijisha and Bhooshan Saro serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U72900KA2016PTC098692
- Company No.
098692
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Dec 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Series 5 Labs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhooshan Saro  | Director | 15-Jun-2018 | Current |
| Karakkad Vijisha | Director | 22-Dec-2016 | Current |
Financial Performance of Series 5 Labs.
Series 5 Labs Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 624.14% increase. The company also saw a substantial fall in profitability, with a 20.75% decrease in profit. The company's net worth observed a substantial decline by a decrease of 30.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Series 5 Labs?
In 2018, Series 5 Labs had a promoter holding of 95.00% and a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Connect2sun Technologies Private LimitedKarakkad Vijisha and Bhooshan Saro are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Series 5 Labs?
Unlock and access historical data on people associated with Series 5 Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Series 5 Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Series 5 Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
